WMJ Vol 124 Issue 2: Wisconsin Young Adults’ Attitudes, Beliefs, Motivations, and Behaviors Surrounding E-Cigarette Use and Cessation

ABSTRACT

Introduction: Electronic cigarette (e-cigarette) use is prevalent among young adults, yet cessation treatment options are limited and underutilized.

Methods: Wisconsin residents aged 18 to 24 who had vaped nicotine in the past month (N = 480) completed an online survey assessing vaping initiation, past quit experiences, future quit intentions, and treatment knowledge and preferences. The survey also assessed perceived physical and mental health harms of vaping nicotine and other products (eg, cannabis, cannabidiol).

Results: Most young adults had made a prior e-cigarette quit attempt, commonly motivated by concerns about addiction, cost, and health problems. Though 80% want support to quit, preferred methods of support were highly variable. The same methods (eg, medication, friends/family, health care provider, therapist) that were most endorsed as the form of support young adults were most likely to use were also among the most endorsed forms of support that young adults would not want to use. Nearly 40% of participants reported vaping cannabis and perceived vaping cannabis as significantly less harmful than vaping nicotine or tobacco for physical and mental health.

Conclusions: Vaping cessation resources that are responsive to young adults’ needs and preferences are needed. The high variability in treatment preferences suggests that multiple strategies need to be offered; there is no one-size-fits-all approach. Cannabis vaping is prevalent, and an important area for future research is to examine the impact of cannabis vaping on nicotine vaping dependence, cessation, and treatment use. Strategies to reach, motivate, and engage young adults in e-cigarette cessation and cessation treatment should highlight their concerns about addiction, costs, health harms, and desired treatment options.
 

Intended Audience

The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.

Learning Objectives

As a result of participating in this journal-based activity, healthcare team members will be able to:

  1. Summarize young adults' knowledge and perceptions about health harms related to vaping.
  2. Explain survey findings on young adults’ e-cigarette use initiation, past quit experiences, future quit intentions, and treatment knowledge and preferences.
  3. Discuss strategies that healthcare teams can use to reach, motivate, and engage young adults in e-cigarette cessation treatment.
Course summary
Available credit: 
  • 0.75 AAPA Category 1 CME
  • 0.75 ACPE Contact Hours - Pharmacist
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™
Registration opens: 
05/26/2026
Course expires: 
05/25/2027
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name of IndividualIndividual's Role in ActivityFinancial Relationship DisclosureDiscussion of Unlabeled/Unapproved Uses of Drugs/Devices
Marianna Shershneva, MD, PhDAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
James Eberhard, MFAAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
Jesse T. Kaye, PhDAuthorNo relevant relationships with ineligible companies to discloseNo
Brian S. Williams, MDAuthorNo relevant relationships with ineligible companies to discloseNo
Jennifer Bird, PhDAuthorNo relevant relationships with ineligible companies to discloseNo
Karen L. Conner, MPHAuthorNo relevant relationships with ineligible companies to discloseNo
Rob Adsit, MEdAuthorNo relevant relationships with ineligible companies to discloseNo
Megan E. Piper, PhDAuthorNo relevant relationships with ineligible companies to discloseNo
Kwanza Devlin, MDReviewerNo relevant relationships with ineligible companies to discloseNo
Fahad Aziz, MDEditorNo relevant relationships with ineligible companies to discloseNo
Katie Gillespie, DNP, RN, CPH, FAANReviewerNo relevant relationships with ineligible companies to discloseNo
Cassie Meffert, PAC, MPHReviewerNo relevant relationships with ineligible companies to discloseNo
Sue Wenker, PT, PhD, MS, FNAPReviewerNo relevant relationships with ineligible companies to discloseNo

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

Discloser List CME Internal Report

Accreditation and Credit Designation Statements

Accreditation Logos

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 ANCC contact hour.  

American Academy of Physician Assistants (AAPA)

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 03/25/2027. PAs should only claim credit commensurate with the extent of their participation.

 

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this knowledge-based activity for 0.75 hours or 0.075 CEUs. Credit can be earned by successfully completing the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

UAN:  

 

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.075 continuing education units (CEUs) or 0.75 hours.

Available Credit

  • 0.75 AAPA Category 1 CME
  • 0.75 ACPE Contact Hours - Pharmacist
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

Accessibility

If you need anything to participate in this program, please contact [email protected].

Required Hardware/software

Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.